Comparison of the expression profile of apoptosis-associated genes in rheumatoid arthritis and osteoarthritis

Rheumatology International

Volumn 28, Issue 7, 2008, Pages 697-701

  Qingchun, Huang ^a   Runyue, Huang ^a   LiGang, Jie ^a   Yongliang, Chu ^a   Song, Wei ^a   Shujing, Zhao ^a  

^a Guangzhou Liuhuaqiao Hospital   (China)

Author keywords

Apoptosis; DNA microarray; Osteoarthritis; Rheumatoid arthritis; Synovial hyperplasia

Indexed keywords

ACTININ; ACTININ ALPHA1; ADAPTOR PROTEIN; ENGULFMENT ADAPTOR PTB DOMAIN CONTAINING 1; GRANZYME A; INTERLEUKIN 2 RECEPTOR ALPHA; PROTEIN BCL 2; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; RING FINGER PROTEIN; RING FINGER PROTEIN 34; RNA; SOMATOMEDIN C RECEPTOR; TRANSGLUTAMINASE 2; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE LOCUS; GENE TARGETING; HUMAN; HUMAN TISSUE; JOINT BIOPSY; MICROARRAY ANALYSIS; OSTEOARTHRITIS; PATHOGENESIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RNA HYBRIDIZATION; UPREGULATION;

ACTININ; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADOLESCENT; ADULT; AGED; APOPTOSIS; ARTHRITIS, RHEUMATOID; GENE EXPRESSION PROFILING; GRANZYMES; HUMANS; MIDDLE AGED; OSTEOARTHRITIS; RECEPTOR, IGF TYPE 1;

EID: 41849142292     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-008-0534-7     Document Type: Article

References (26)

1. Gay S, Gay RE, Koopman WJ (1993) Molecular and cellular mechanism of joint destruction in rheumatoid arthritis: two cellar mechanisms explain joint destruction. Ann Rheum Dis 52:39-47
2. MacKenzie NM (2006) New therapeutics that treat rheumatoid arthritis by blocking T-cell activation. Drug Discov Today 11:952-956
3. Hui A, Kulkarni GV, Hunter WL, McCulloch CA, Cruz TF (1997) Paclitaxel selectively induces mitotic arrest and apoptosis in proliferating bovine synoviocytes. Arthritis Rheum 40:1073-1084
4. Nakajima T, Aono H, Hasunuma T, Yamamoto K, Shirai T, Hirohata K, Nishioka K (1995) Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes. Arthritis Rheum 38:485-491
5. Ceponis A, Hietanen J, Tamulaitiene M, Partsch G, Pätiälä H, Konttinen YT (1999) A comparative quantitative morphometric study of cell apoptosis in synovial membranes in psoriatic, reactive and rheumatoid arthritis. Rheumatology (Oxford) 38:431-440
6. Kobayashi T, Okamoto K, Kobata T, Hasumuna T, Nishioka K (1999) Apomodulation as a novel therapeutic concept for the regulation of apoptosis in rheumatoid synoviocytes. Curr Opin Rheumatol 11:188-193
7. Wolfe F, Michaud K (2007) Resistance of rheumatoid arthritis patients to changing therapy: discordance between disease activity and patients' treatment choices. Arthritis Rheum 56:2135-2142 [Epub ahead of print]
8. Bernatsky S, Hudson M, Suissa S (2007) Anti-rheumatic drug use and risk of serious infections in rheumatoid arthritis. Rheumatology (Oxford) 46:1157-1160
9. Buch MH, Bingham SJ, Bryer D, Emery P (2007) Long-term infliximab treatment in rheumatoid arthritis: subsequent outcome of initial responders. Rheumatology (Oxford) 46:1153-1156
10. Mountz JD, Wu J, Cheng H, Zhou T (1994) Autoimmune disease: a problem of defective apoptosis. Science 37:1415-1420
11. Ogawa N, Dang H, Hald N (1995) Apoptosis and autoimmunity. J Antoimmun 8:1-19
12. Firestein GS, Nguyen K, Aupperle KR, Yeo M, Boyle DL, Zvaifler NJ (1996) Apoptosis in rheumatoid arthritis: p53 overexpression in rheumatoid arthritis synovium. Am J Pathol 149:2143-2151
13. Triplett JW, Pavalko FM (2006) Disruption of alpha-actinin-integrin interactions at focal adhesions renders osteoblasts susceptible to apoptosis. Am J Physiol Cell Physiol 291:C909-C921
14. Sasaki S, Nakamura T, Arakawa H, Mori M, Watanabe T, Nagawa H, Croce CM (2002) Isolation and characterization of a novel gene, hRFI, preferentially expressed in esophageal cancer. Oncogene 21:5024-5030
15. Sasaki S, Watanabe T, Konishi T, Kitayama J, Nagawa H (2004) Effects of expression of hRFI on adenoma formation and tumor progression in colorectal adenoma - carcinoma sequence. J Exp Clin Cancer Res 23:507-512
16. Galvan V, Logvinova A, Sperandio S, Ichijo H, Bredesen DE (2003) Type 1 insulin-like growth factor receptor (IGF-IR) signaling inhibits apoptosis signal-regulating kinase 1 (ASK1). J Biol Chem 278:13325-13332
17. Zwerina J, Hayer S, Redlich K, Bobacz K, Kollias G, Smolen JS, Schett G (2006) Activation of p38 MAPK is a key step in tumor necrosis factor-mediated inflammatory bone destruction. Arthritis Rheum 54:463-472
18. Nakajima K, Hirose H, Taniguchi M, Kurashina H, Arasaki K, Nagahama M, Tani K, Yamamoto A, Tagaya M (2004) Involvement of BNIP1 in apoptosis and endoplasmic reticulum membrane fusion. EMBO J 23:3216-3226
19. Mishra S, Murphy LJ (2006) The p53 oncoprotein is a substrate for tissue transglutaminase kinase activity. Biochem Biophys Res Commun 339:726-730
20. Davila E, Kang YM, Park YW, Sawai H, He X, Pryshchep S, Goronzy JJ, Weyand CM (2005) Cell-based immunotherapy with suppressor CD8 + T cells in rheumatoid arthritis. J Immunol 174:7292-7301
21. Ehinger M, Vestberg M, Johansson AC, Johannesson M, Svensson A, Holmdahl R (2001) Influence of CD4 or CD8 deficiency on collagen-induced arthritis. J Immunol 103:291-300
22. Taneja V, Taneja N, Paisansinsup T, Behrens M, Griffiths M, Luthra H, David CS (2002) CD4 and CD8 T cells in susceptibility/protection to collagen-induced arthritis in HLA-DQ8-transgenic mice: implications for rheumatoid arthritis. J Immunol 168:5867-5875
23. Mohan K, Pinto D, Issekutz TB (2003) Identification of tissue transglutaminase as a novel molecule involved in human CD8+ T cell transendothelial migration. J Immunol 171:3179-3186
24. Fan Z, Beresford PJ, Zhang D, Xu Z, Novina CD, Yoshida A, Pommier Y, Lieberman J (2003) Cleaving the oxidative repair protein Ape1 enhances cell death mediated by granzyme A. Nat Immunol 4:106-108
25. Su HP, Nakada-Tsukui K, Tosello-Trampont AC, Li Y, Bu G, Henson PM, Ravichandran KS (2002) Interaction of CED-6/GULP, an adapter protein involved in engulfment of apoptotic cells with CED-1 and CD91/low density lipoprotein receptor-related protein (LRP). J Biol Chem 277:11772-11779
26. Sharfe N, Dadi HK, Shahar M, Roifman CM (1997) Human immune disorder arising from mutation of the alpha chain of the interleukin-2 receptor. Proc Natl Acad Sci USA 4:3168-3171